Thimble Point Acquisition Corp Cl A (THMA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
9.30 +0.18 (+1.97%) 12/03/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 9.30 unch (unch) -
for Fri, Dec 3rd, 2021
Results
download Want to compare other data? Select Fields| Symbol | THMA | EPIX | SAVA | ||
| Company | Thimble Point Acquisition Corp Cl A | Essa Pharma | Cassava Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.15 | 1.7700 | 1.5400 | ||
| High | 9.33 | 1.8500 | 1.5900 | ||
| Low | 9.15 | 1.7500 | 1.4800 | ||
| Last | 9.30 | 1.8200 | 1.5600 | ||
| Change | +0.18 | +0.0500 | unch | ||
| % Change | +1.93% | +2.82% | unch | ||
| Volume | 700 | 181,200 | 633,300 | ||
| 20-Day Average Volume | 281,600 | 259,545 | 1,021,730 | ||
| Previous Close | 9.12 | 1.7700 | 1.5600 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.83 | 1.6635 | 1.4205 | ||
| 20-Day Raw Stochastic | 26.62% | 82.47% | 70.69% | ||
| 20-Day Relative Strength | 23.36% | 61.81% | 39.95% | ||
| Weighted Alpha | -9.39 | -17.73 | -65.80 | ||
| Today's Opinion | N/A | 24% Sell | 88% Sell | ||
| Previous Opinion | N/A | 24% Sell | 88% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.34% since 11/26/21 | +3.41% since 04/23/25 | -6.02% since 04/23/25 | ||
| Low | 9.01 on 12/02/21 | 1.7400 on 04/29/25 | 1.4800 on 04/30/25 | ||
| High | 10.10 on 11/29/21 | 1.9050 on 04/24/25 | 1.7000 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | -6.72% since 11/03/21 | +16.67% since 03/28/25 | -5.45% since 03/28/25 | ||
| Low | 9.01 on 12/02/21 | 1.4200 on 04/09/25 | 1.1500 on 04/10/25 | ||
| High | 10.10 on 11/29/21 | 1.9050 on 04/24/25 | 1.7300 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -6.06% since 09/03/21 | +5.20% since 01/30/25 | -34.45% since 01/30/25 | ||
| Low | 9.01 on 12/02/21 | 1.4200 on 04/09/25 | 1.1500 on 04/10/25 | ||
| High | 10.10 on 11/29/21 | 1.9050 on 04/24/25 | 3.0500 on 03/18/25 | ||
| 6-Month | |||||
| %Chg | -4.12% since 06/03/21 | -65.53% since 10/30/24 | -94.00% since 10/30/24 | ||
| Low | 9.01 on 12/02/21 | 1.4000 on 11/01/24 | 1.1500 on 04/10/25 | ||
| High | 10.10 on 11/29/21 | 5.3800 on 10/31/24 | 33.9800 on 11/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,361 | 78,569 | 75,360 | ||
| Shares Outstanding, K | 8,211 | 44,389 | 48,308 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | -28,540,000 | -24,340,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | 5,830,000 | -8,530,000 | -27,600,000 | ||
| 60-Month Beta | N/A | 1.61 | -1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/05/21 | -0.19 on 02/11/25 | -0.57 on 03/03/25 | ||
| Latest Earnings Date | N/A | 05/13/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | 0.750 on 12/13/12 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||